EP Patent

EP1490030B2 — Nanoparticulate compositions of angiogenesis inhibitors

Assigned to Perrigo Pharma International DAC · Expires 2010-07-14 · 16y expired

What this patent protects

Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making …

USPTO Abstract

Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1490030B2
Jurisdiction
EP
Classification
—
Expires
2010-07-14
Drug substance claim
No
Drug product claim
No
Assignee
Perrigo Pharma International DAC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.